Literature DB >> 24576640

Proteomics on porcine haptoglobin and IgG/IgA show protein species distribution and glycosylation pattern to remain similar in PCV2-SD infection.

Anna Marco-Ramell1, Ingrid Miller2, Katharina Nöbauer3, Uwe Möginger4, Joaquim Segalés5, Ebrahim Razzazi-Fazeli3, Daniel Kolarich4, Anna Bassols6.   

Abstract

Haptoglobin (Hp) and immunoglobulins are plasma glycoproteins involved in the immune reaction of the organism after infection and/or inflammation. Porcine circovirus type 2-systemic disease (PCV2-SD), formerly known as postweaning multisystemic wasting syndrome (PMWS), is a globally spread pig disease of great economic impact. PCV2-SD affects the immunological system of pigs causing immunosuppression. The aim of this work was to characterize the Hp protein species of healthy and PCV2-SD affected pigs, as well as the protein backbone and the glycan chain composition of porcine Hp. PCV2-SD affected pigs had an increased overall Hp level, but it did not affect the ratio between Hp species. Glycoproteomic analysis of the Hp β subunits confirmed that porcine Hp is N-glycosylated and, unexpectedly, O-glycosylated, a PTM that is not found on Hp from healthy humans. The glyco-profile of porcine IgG and IgA heavy chains was also characterized; decreased levels of both proteins were found in the investigated group of PCV2-SD affected pigs. Obtained results indicate that no significant changes in the N- and O-glycosylation patterns of these major porcine plasma glycoproteins were detectable between healthy and PCV2-SD affected animals. BIOLOGICAL SIGNIFICANCE: PCV2-SD is a disease of great economic importance for pig production, characterized by a complex response of the immune system. In the search of a better diagnostic/prognostic marker for porcine PCV2-SD, extensive analyses of the Hp protein backbone and the glycan chains were thoroughly analyzed by various techniques. This resulted in detection and confirmation of Hp O-glycosylation and the glyco-profiling of porcine IgG and IgA. The N- and O-glycosylation of these major porcine plasma glycoproteins appears to be not affected by PCV2-SD infection. Interestingly, these data suggest that this viral infection, which significantly affects the immune responses of the host, leaves the biosynthetic glycosylation processes in the liver and immune cells unaffected. Lack of PTM changes is in contrast to findings in humans where for both proteins pattern changes have been reported in several chronic and inflammatory diseases. This underlines the importance of studying species in detail and not reaching to conclusions by analogy. Furthermore, since Hp is usually quantified by immunoassays in clinical routine analyses, our findings indicate that no bias in Hp determination capabilities due to an altered carbohydrate pattern is to be expected.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Glycosylation; Haptoglobin; Immunoglobulins; Pig/porcine; Porcine circovirus type 2 (PCV2)

Mesh:

Substances:

Year:  2014        PMID: 24576640     DOI: 10.1016/j.jprot.2014.02.018

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  3 in total

1.  Characterization of N-glycosylation and amino acid sequence features of immunoglobulins from swine.

Authors:  Paul G Lopez; Lauren Girard; Marjorie Buist; Andrey Giovanni Gomes de Oliveira; Edward Bodnar; Apolline Salama; Jean-Paul Soulillou; Hélène Perreault
Journal:  Glycoconj J       Date:  2015-11-19       Impact factor: 2.916

2.  Large-Scale Purification of r28M: A Bispecific scFv Antibody Targeting Human Melanoma Produced in Transgenic Cattle.

Authors:  Katrin Spiesberger; Florian Paulfranz; Anton Egger; Judith Reiser; Claus Vogl; Judith Rudolf-Scholik; Corina Mayrhofer; Ludger Grosse-Hovest; Gottfried Brem
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

3.  Quantification of Intact O-Glycopeptides on Haptoglobin in Sera of Patients With Hepatocellular Carcinoma and Liver Cirrhosis.

Authors:  Hong Shu; Lei Zhang; Yiwei Chen; Yijie Guo; Limin Li; Fanghua Chen; Zhao Cao; Guoquan Yan; Chunlai Lu; Chao Liu; Shu Zhang
Journal:  Front Chem       Date:  2021-07-14       Impact factor: 5.221

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.